首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Regiospecific synthesis and biological evaluation of spirooxindolopyrrolizidines via (3+2) cycloaddition of azomethine ylide.
【24h】

Regiospecific synthesis and biological evaluation of spirooxindolopyrrolizidines via (3+2) cycloaddition of azomethine ylide.

机译:经由(3 + 2)环加成的甲亚胺叶立德的螺区毒素合成吡咯并吡咯并核苷的区域特异性和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Reaction of (E)-3-aryl-1-(thiophen-2-yl)prop-2-en-1-ones with azomethine ylide (generated in situ via decarboxylative condensation of isatin with l-proline) in refluxing methanol afforded 1'-(aryl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2-ones as the sole product in a regiospecific manner. The synthesized compounds have been characterized by their elemental, analytical and spectral studies. The synthesized compounds were screened for their antibacterial and antifungal activities against a spectrum of microbial organisms. These studies proved that compounds 1'-(p-chlorophenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2 -one (4b), 1'-(p-fluorophenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2 -one (4d) and 1'-(p-methoxyphenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]- 2-one (4h) against Staphylococcus aureus, 1'-(p-chlorophenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2 -one (4b), 1'-(p-methylphenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2 -one (4c) and 1'-(p-fluorophenyl)-2'-(2-thienylcarbonyl)-spiro[3H-indole-3,3'-[3H]pyrrolizin]-2 -one (4d) against Salmonella typhi show maximum inhibition potency at low concentration (6.25 mug/mL) whereas 4d against Candida albicans and 4b and 4d against Rhizopus sp. showed beneficial antifungal activity at minimum concentration.
机译:(E)-3-芳基-1-(噻吩-2-基)丙-2-烯-1-酮与偶氮甲ine内酯(通过Isatin与L-脯氨酸的脱羧缩合原位生成)在回流的甲醇中反应,得到1 '-(芳基)-2'-(2-噻吩基羰基)-螺[3H-吲哚-3,3'-[3H]吡咯嗪] -2-酮为区域特异性的唯一产物。合成的化合物已通过其元素,分析和光谱研究进行了表征。筛选合成的化合物对各种微生物的抗菌和抗真菌活性。这些研究证明了化合物1'-(对氯苯基)-2'-(2-噻吩基羰基)-螺[3H-吲哚-3,3'-[3H]吡咯烷] -2-一(4b),1'- (对氟苯基)-2'-(2-噻吩基羰基)-螺[3H-吲哚-3,3'-[3H]吡咯嗪] -2-一个(4d)和1'-(对甲氧基苯基)-2' -(2-噻吩基羰基)-螺[3H-吲哚-3,3'-[3H]吡咯嗪] -2-酮(4h),针对金黄色葡萄球菌,1'-(对氯苯基)-2'-(2-噻吩基羰基) )-螺[3H-吲哚-3,3'-[3H]吡咯嗪] -2-一(4b),1'-(对甲基苯基)-2'-(2-噻吩基羰基)-螺[3H-吲哚- 3,3'-[3H]吡咯嗪] -2-一(4c)和1'-(对氟苯基)-2'-(2-噻吩基羰基)-螺[3H-吲哚-3,3'-[3H]对伤寒沙门氏菌的吡咯并[-1] -2-(4天)在低浓度(6.25杯/毫升)时显示最大的抑制效力,而对白色念珠菌为4d,对根霉属为4b和4d。在最小浓度下显示出有益的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号